You are not imagining it. The burning, the itching, the painful sex — these symptoms started somewhere around your last period, and they have not let up since. Vaginal dryness after menopause is not a hygiene issue or a personality flaw. It is a hormonal cascade with a name: Genitourinary Syndrome of Menopause (GSM).
At Aguirre Specialty Care in Parker, Colorado, Dr. Oscar A. Aguirre — a fellowship-trained urogynecologist — treats GSM every week. The condition is common, undertreated, and reversible. Below is how estrogen loss reshapes the vaginal tissue, and how the right combination of local estrogen therapy and FemiLift laser treatment restores comfort.
What is Genitourinary Syndrome of Menopause (GSM)?
Genitourinary Syndrome of Menopause (GSM) is a chronic condition caused by declining estrogen, characterized by thinning of the vaginal mucosa, reduced lubrication, decreased elasticity, and irritation of the urinary tract. GSM affects up to 50% of postmenopausal women and produces symptoms such as vaginal dryness, painful intercourse, burning, and recurrent urinary tract infections.
Sound familiar? You are not broken — your tissue is simply running on less fuel than it used to. Here is how that fuel shortage actually works.
How Estrogen Loss Changes Vaginal Tissue
Estrogen is the architect of healthy vaginal tissue. When estrogen levels fall during perimenopause and menopause, the tissue changes happen in three measurable stages:
- Thinning of the mucosa. Estrogen plumps the cells lining the vaginal canal. Without it, those cells flatten, and the lamina propria — the connective tissue layer beneath the surface — loses thickness.
- Reduced glycogen and friendly bacteria. Healthy vaginal cells produce glycogen, which feeds the Lactobacilli that keep vaginal pH acidic. Less estrogen means less glycogen, fewer Lactobacilli, and a higher pH — which invites irritation and infection.
- Loss of collagen and elasticity. Estrogen stimulates fibroblasts, the cells that produce collagen. When estrogen drops, fibroblasts slow down, and the vaginal walls lose stretch.
The result is a tissue environment that bruises easily, dries quickly, and burns during intercourse. And it does not fix itself.
Why “Just Use a Lubricant” Falls Short
Lubricants make the moment more comfortable. They do not rebuild the tissue. You can layer on the highest-quality gel and still wake up tomorrow with the same atrophic mucosa, the same fragile lining, the same recurring UTIs. Lubricants treat the symptom; estrogen restoration treats the cause.
The Two-Track Approach at Aguirre Specialty Care
Dr. Aguirre treats GSM with a coordinated protocol that addresses both the hormone deficit and the tissue damage. Most patients see meaningful results within 8 to 12 weeks.
Track 1: Local Estrogen Therapy
Local estrogen — delivered as a vaginal cream, tablet, or ring — restores estrogen directly to the vaginal tissue without circulating through the bloodstream the way systemic hormones do. The hormone enters the lamina propria, reawakens fibroblast activity, and rebuilds the mucosa from within.
Local estrogen is appropriate for most women, including many breast cancer survivors (in coordination with their oncologist). The North American Menopause Society and the American College of Obstetricians and Gynecologists both endorse local estrogen as a first-line medical treatment for GSM. For women considering a broader menopause-care plan, Aguirre Specialty Care also offers Bioidentical Hormone Replacement Therapy as part of an individualized hormone strategy.
Track 2: FemiLift Laser Treatment
For women who cannot use estrogen — or who want a faster, non-hormonal option — FemiLift offers a parallel path. FemiLift is a fractional CO2 laser that delivers controlled micro-thermal columns into the vaginal wall. These micro-injuries trigger collagen remodeling, which essentially means the tissue rebuilds itself in response to the laser stimulus, mimicking what estrogen does naturally.
Here is the clinical sequence:
- The fractional CO2 laser creates micro-channels in the vaginal mucosa.
- The controlled injury activates fibroblasts to produce new collagen and elastin.
- Over 8 to 12 weeks, the tissue thickens, lubrication returns, and elasticity improves.
The standard FemiLift protocol at Aguirre Specialty Care is three in-office sessions, spaced four weeks apart. No anesthesia, no downtime.
When to Combine Both Treatments
For women with moderate to severe GSM, combining local estrogen with FemiLift produces the strongest results. Estrogen rebuilds the cellular environment from the inside; FemiLift accelerates collagen production from the surface. Dr. Aguirre often recommends this dual protocol for women who:
- Have failed lubricants and topical moisturizers alone.
- Experience recurrent UTIs alongside vaginal dryness.
- Have painful intercourse (dyspareunia) that disrupts intimacy.
- Want measurable tissue restoration, not just symptom masking.
Local Estrogen vs. FemiLift: Side-by-Side
|
Feature |
Local Estrogen |
FemiLift
|
|---|---|---|
|
Mechanism |
Hormonal — restores estrogen to tissue |
Thermal — stimulates collagen via fractional CO2 laser |
|
Delivery |
Cream, tablet, or ring |
In-office laser procedure |
|
Full effect |
6 to 12 weeks |
8 to 12 weeks after 3 sessions |
|
Hormone use |
Yes (local only) |
No hormones |
|
Frequency |
Daily to twice weekly |
3 sessions, 4 weeks apart |
|
Best for |
Most postmenopausal women |
Hormone-restricted patients, faster non-hormonal results |
Why Dr. Aguirre’s Experience Matters
Dr. Aguirre completed a two-year fellowship in urogynecology and reconstructive pelvic surgery and has been recognized by peers as a Top Doc in Female Pelvic Medicine and Reconstructive Surgery. He has been treating GSM in the Denver area since 1999 — which means he has seen every variation of this condition, including the ones previous providers told you to “live with.”
You do not have to live with it.
Frequently Asked Questions
Is local estrogen safe?
Local estrogen has a meaningfully different safety profile from systemic hormone therapy because the hormone stays largely in the vaginal tissue. The American College of Obstetricians and Gynecologists, the North American Menopause Society, and the Endocrine Society endorse local estrogen as first-line for GSM. Your individual medical history determines what is appropriate for you, which is why Dr. Aguirre reviews it carefully before prescribing.
How is FemiLift different from radiofrequency treatments like Morpheus8V?
FemiLift uses fractional CO2 laser energy; Morpheus8V uses radiofrequency through tiny needles. Both stimulate collagen, but they reach different tissue depths. Dr. Aguirre selects between them — or combines them — based on which symptoms dominate and which tissue layer needs the most attention.
Will insurance cover GSM treatment?
Local estrogen prescriptions are often covered by insurance. FemiLift is generally considered an aesthetic-medical service and is paid out of pocket. The Aguirre Specialty Care team can walk you through specifics during your consultation.
How soon will I feel a difference?
Most women feel meaningful relief from local estrogen within 4 to 6 weeks. FemiLift results build over 8 to 12 weeks as the new collagen matures and the vaginal mucosa thickens.
Ready for Real Answers, Not More Lubricant?
Vaginal dryness deserves a real diagnosis and a real treatment plan. Schedule your GSM evaluation with Dr. Aguirre at Aguirre Specialty Care in Parker, Colorado.
Aguirre Specialty Care — specialized urogynecology and intimate wellness for women across the Denver area.
